Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Beckman Coulter
So what: Citing sources close to the matter, The Wall Street Journal said Beckman could fetch as much as $5 billion in sale, representing a 25% premium to its closing market cap value on Thursday. The news comes amid heavy consolidation in the medical device sector, with the likes of General Electric
Now what: I'd keep my distance from Beckman's shares at this point. The company has hired Goldman Sachs
Interested in more info on Beckman? Add it to your watchlist.